NYSE - Delayed Quote USD

Envista Holdings Corporation (NVST)

Compare
20.52 +0.53 (+2.65%)
At close: December 11 at 4:00:02 PM EST
20.56 +0.04 (+0.19%)
After hours: December 11 at 5:44:21 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,503,300.00
2,566,500.00
2,569,100.00
2,508,900.00
1,929,100.00
Cost of Revenue
1,167,200.00
1,126,000.00
1,094,300.00
1,082,400.00
874,300.00
Gross Profit
1,336,100.00
1,440,500.00
1,474,800.00
1,426,500.00
1,054,800.00
Operating Expense
1,211,100.00
1,150,700.00
1,155,600.00
1,120,300.00
1,011,300.00
Operating Income
125,000.00
289,800.00
319,200.00
306,200.00
43,500.00
Net Non Operating Interest Income Expense
-50,400.00
-63,400.00
-38,400.00
-54,100.00
-62,500.00
Other Income Expense
-1,410,800.00
-281,300.00
3,100.00
2,400.00
-1,000.00
Pretax Income
-1,336,200.00
-54,900.00
283,900.00
254,500.00
-20,000.00
Tax Provision
1,000.00
45,300.00
45,900.00
-9,000.00
-62,500.00
Net Income Common Stockholders
-1,337,200.00
-100,200.00
243,100.00
340,500.00
33,300.00
Diluted NI Available to Com Stockholders
-1,337,200.00
-100,200.00
243,100.00
340,500.00
33,300.00
Basic EPS
-7.82
-0.60
1.49
2.11
0.21
Diluted EPS
-7.82
-0.60
1.37
1.92
0.20
Basic Average Shares
172,000.00
166,900.00
162,900.00
161,200.00
159,600.00
Diluted Average Shares
172,000.00
166,900.00
177,600.00
177,600.00
164,100.00
Total Operating Income as Reported
-1,287,100.00
31,500.00
319,200.00
306,200.00
43,500.00
Total Expenses
2,378,300.00
2,276,700.00
2,249,900.00
2,202,700.00
1,885,600.00
Net Income from Continuing & Discontinued Operation
-1,337,200.00
-100,200.00
243,100.00
340,500.00
33,300.00
Normalized Income
-221,641.00
103,857.00
238,000.00
263,500.00
42,500.00
Interest Expense
50,400.00
63,400.00
38,400.00
54,100.00
62,500.00
Net Interest Income
-50,400.00
-63,400.00
-38,400.00
-54,100.00
-62,500.00
EBIT
-1,285,800.00
8,500.00
322,300.00
308,600.00
42,500.00
EBITDA
-1,127,400.00
171,100.00
484,400.00
460,500.00
205,600.00
Reconciled Cost of Revenue
1,167,200.00
1,126,000.00
1,094,300.00
1,082,400.00
874,300.00
Reconciled Depreciation
158,400.00
162,600.00
162,100.00
151,900.00
163,100.00
Net Income from Continuing Operation Net Minority Interest
-1,337,200.00
-100,200.00
238,000.00
263,500.00
42,500.00
Total Unusual Items Excluding Goodwill
-1,412,100.00
-258,300.00
--
--
--
Total Unusual Items
-1,412,100.00
-258,300.00
--
--
--
Normalized EBITDA
284,700.00
429,400.00
484,400.00
460,500.00
205,600.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-296,541.00
-54,243.00
--
--
--
12/31/2020 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XRAY DENTSPLY SIRONA Inc.
20.03
+2.46%
 
AVTR Avantor, Inc.
22.66
+0.98%
 
AZTA Azenta, Inc.
45.91
-0.97%
 
RGEN Repligen Corporation
155.25
+2.18%
 
ICUI ICU Medical, Inc.
166.19
+3.80%
 
STMN.SW Straumann Holding AG
118.15
+0.85%
 
LMAT LeMaitre Vascular, Inc.
101.00
+1.61%
 
STVN Stevanato Group S.p.A.
21.76
+2.16%
 
ALGN Align Technology, Inc.
239.52
+1.00%
 
MMSI Merit Medical Systems, Inc.
105.52
+1.67%